The influence of ICRF-159 and levamisole on the incidence of metastases following local irradiation of a solid tumor
Open Access
- 15 November 1981
- Vol. 48 (10) , 2179-2183
- https://doi.org/10.1002/1097-0142(19811115)48:10<2179::aid-cncr2820481011>3.0.co;2-u
Abstract
Courses of irradiation consisting of 6000 rad in ten equal fractions over 12 days delivered to KHT sarcomas in mice controlled 55% of the local tumors but 83% of the mice died from metastases. Three strategies to reduce the risk of metastatic spread were tested. The fractionation scheme was changed to deliver the same total dose using a large initial fraction followed by seven equal portions with the same overall time. ICRF‐159 was used with the intention of partially synchronizing the tumor growth fraction in a radiosensitive state of the growth cycle and of promoting normalization of the tumor vasculature. Levamisole was used to stimulate the immune system. The combination of ICRF‐159 with the eight‐fraction radiation course proved to be effective for both increasing local control and decreasing the incidence of metastases. The addition of levamisole did not improve the results obtained with a combination of ICRF‐159 and irradiation.This publication has 13 references indexed in Scilit:
- An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tractsCancer, 1977
- Effect of dose rate on production of early and late radiation damage in mouse skinInternational Journal of Radiation Oncology*Biology*Physics, 1977
- The effect of (±) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphomaPublished by Elsevier ,1975
- Exploitation of Kinetic Differences between Normal and Malignant CellsRadiology, 1975
- Selective cytotoxicity of peritoneal leucocytes for neoplastic cellsCellular Immunology, 1973
- High dose pre‐operative radiotherapy and surgery for cancer of the larynx.The Laryngoscope, 1972
- Rubella vaccination.BMJ, 1972
- Inhibition of Metastatic Spread by I.C.R.F. 159: Selective Deletion of a Malignant CharacteristicBMJ, 1970
- Postoperative Radiotherapy in the Treatment of Breast CancerAnnals of Surgery, 1970
- Mode of Action of the Cytostatic Agent ‘ICRF 159’Nature, 1970